(Q51861342)

14 April 2018

title

Patient-controlled analgesic therapy, Part III: pharmacokinetics and analgesic plasma concentrations of ketobemidone. (English)

1 reference

14 April 2018

1 reference

A Tamsen

1

1 reference

14 April 2018

U Bondesson

series ordinal

2

1 reference

14 April 2018

B Dahlström

series ordinal

3

1 reference

14 April 2018

P Hartvig

series ordinal

4

1 reference

14 April 2018

publication date

1 May 1982

1 reference

14 April 2018

Clinical Pharmacokinetics

published in

1 reference

14 April 2018

volume

7

1 reference

14 April 2018

issue

3

1 reference

14 April 2018

page(s)

252-265

1 reference

14 April 2018

Patient-controlled analgesic therapy, Part II: Individual analgesic demand and analgesic plasma concentrations of pethidine in postoperative pain.

cites work

1 reference

12 December 2020

Mass fragmentographic method for the determination of ketobemidone in plasma

1 reference

12 December 2020

Clinical pharmacokinetics of ketobemidone. Its bioavailability after rectal administration

1 reference

12 December 2020

Effects of heat and exercise on the elimination of pralidoxime in man.

1 reference

12 December 2020

The effect of hypercapnia on estimated hepatic blood flow, circulating splanchnic blood volume, and hepatic sulfobromophthalein clearance during general anesthesia in man.

1 reference

12 December 2020

Alterations in Distribution Volume and Biological Half-Life of Cortisol During Major Surgery

1 reference

12 December 2020

Influence of abdominal surgical trauma and intra-operative infusion of glucose on splanchnic glucose metabolism in man.

1 reference

12 December 2020

The analgesic properties and addiction liability of ketobemidone and morphine

1 reference

12 December 2020

Clinical pharmacokinetics and oral bioavailability of ketobemidone

1 reference

12 December 2020

Patient-controlled analgesic therapy. Part I: Pharmacokinetics of pethidine in the per- and postoperative periods.

1 reference

12 December 2020

Studies on a new spasmolytic compound 1,1-diphenyl-3-dimethylaminobutene-1 (A29), related to methadone, and on the combined use of this compound and a potent analgesic, ketobemidone (A21)

1 reference

12 December 2020

Patient-Controlled Analgesic Therapy: Clinical Experience

1 reference

12 December 2020

Statistical estimations in pharmacokinetics.

1 reference

12 December 2020

Effects of physical stress on the disposition of drugs eliminated by the liver in man

1 reference

12 December 2020

Comparison of Some New Analgesic Compounds

1 reference

12 December 2020

Postoperative hepatic blood flow and its relation to systemic circulation and blood gases during splanchnic blockade and fentanyl analgesia

1 reference

12 December 2020

Patient-controlled analgesic therapy, Part IV: pharmacokinetics and analgesic plasma concentrations of morphine.

1 reference

12 December 2020

Clinical Pharmacokinetics Pethidine

1 reference

12 December 2020

Kinetics of intravenous and intramuscular morphine

1 reference

12 December 2020

10.2165/00003088-198207030-00005

Identifiers

DOI

1 reference

14 April 2018

Dimensions Publication ID

1032375698

0 references

1 reference

14 April 2018